Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

In vitro and In vivo Investigations on Anti-Hyperuricemic Activity of Commercial Preparations of Persicaria minor (Biokesum®) and Eurycoma longifolia (Physta®)

Author(s): Sasikala M. Chinnappan*, Annie George, Yogendra Kumar Choudhary, Ashok Godavarthi, Chi-Ling Teng and Wong Hoi Jin

Volume 9, Issue 5, 2023

Published on: 17 January, 2023

Article ID: e131222211912 Pages: 10

DOI: 10.2174/2215083809666221213142127

Price: $65

Abstract

Background: Eurycoma longifolia Jack (Simaroubaceae) root extracts and Persicaria minor Huds. (Polygonaceae) leaf extracts are known to exhibit antioxidant activity, while their antihyperuricemic effects remain unclear.

Objective: The objective of this study is to investigate the anti-hyperuricemic activity of Biokesum® (extract of P. minor) and Physta® (extract of E. longifolia).

Methods: In vitro anti-hyperuricemic activity for Biokesum® and Physta® was measured by xanthine oxidase inhibition based on a biochemical enzymatic assay at concentrations of 1, 10, and 100 μg/mL. In vivo anti-hyperuricemic activity was assessed in potassium oxonate-induced hyperuricemia Sprague-Dawley rat model. Biokesum® at doses of 100, 300, and 500 mg/kg and Physta® at doses of 300 and 500 mg/kg were administered for 7 days to the hyperuricemic rats. Serum uric acid was measured on days 0, 1, 3, and 7, and liver xanthine oxidase activity was measured on day 8. Allopurinol was used as positive control in both in vitro and in vivo investigations.

Results: Based on xanthine oxidase biochemical enzymatic assay, IC50 of Biokesum® and Physta® were 88.6 μg/mL and > 100 μg/mL respectively. In hyperuricemic rats, Biokesum® and Physta® significantly reduced the serum uric acid by 5.6% and 5.5% respectively at 300 mg/kg (p < 0.05) and 9.8% and 9.0% respectively at 500mg/kg (p < 0.001) compared to untreated rats. Significant liver xanthine oxidase inhibition at 37.5% and 34.1% were observed in rats treated with Biokesum® and Physta® respectively.

Conclusion: The study has demonstrated hyperuricemic activity of Biokesum® and Physta®, clinical studies in hyperuricemia-related diseases population are required to further confirm the activity.

Graphical Abstract

[1]
Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29(11): 2403-6.
[PMID: 12415600]
[2]
Chen H, Zhang C, Yao Y, et al. Study on anti-hyperuricemia effects and active ingredients of traditional Tibetan medicine TongFengTangSan (TFTS) by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 2019; 165: 213-23.
[http://dx.doi.org/10.1016/j.jpba.2018.11.038] [PMID: 30553111]
[3]
Stewart S, Maxwell H, Dalbeth N. Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis. Semin Arthritis Rheum 2019; 49(1): 62-73.
[http://dx.doi.org/10.1016/j.semarthrit.2019.01.004] [PMID: 30709689]
[4]
Kuwabara M, Niwa K, Nishihara S, et al. Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int J Cardiol 2017; 231: 137-42.
[http://dx.doi.org/10.1016/j.ijcard.2016.11.268] [PMID: 27871785]
[5]
Lopez-Pineda A, Cordero A, Carratala-Munuera C, et al. Hyperuricemia as a prognostic factor after acute coronary syndrome. Atherosclerosis 2018; 269: 229-35.
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.01.017] [PMID: 29407598]
[6]
Keen HI, Davis WA, Latkovic E, Drinkwater JJ, Nossent J, Davis TME. Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia: The fremantle diabetes study phase II. J Diabetes Complications 2018; 32(4): 400-5.
[http://dx.doi.org/10.1016/j.jdiacomp.2017.12.015] [PMID: 29483015]
[7]
Xu K, Zhao X, Fu X, et al. Gender effect of hyperuricemia on the development of Nonalcoholic Fatty Liver Disease (NAFLD): A clinical analysis and mechanistic study. Biomed Pharmacother 2019; 117(109158): 109158.
[http://dx.doi.org/10.1016/j.biopha.2019.109158] [PMID: 31252266]
[8]
Chen Y, Li C, Duan S, Yuan X, Liang J, Hou S. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother 2019; 118(109195): 109195.
[http://dx.doi.org/10.1016/j.biopha.2019.109195] [PMID: 31362244]
[9]
Jeon HJ, Oh J, Shin DH. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 – 4 chronic kidney disease: Controversial role of kidney function. PLoS One 2019; 14(6): e0218510.
[http://dx.doi.org/10.1371/journal.pone.0218510] [PMID: 31206563]
[10]
Hou CW, Lee YC, Hung HF, Fu HW, Jeng KC. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity. Am J Chin Med 2012; 40(5): 979-91.
[http://dx.doi.org/10.1142/S0192415X12500723] [PMID: 22928829]
[11]
Zhao R, Chen D, Wu H. Pu-erh ripened tea resists to hyperuricemia through xanthine oxidase and renal urate transporters in hyperuricemic mice. J Funct Foods 2017; 29: 201-7.
[http://dx.doi.org/10.1016/j.jff.2016.12.020]
[12]
Zhang W, Du W, Li G, et al. Constituents and anti-hyperuricemia mechanism of traditional Chinese herbal formulae erding granule. Molecules 2019; 24(18): 3248.
[http://dx.doi.org/10.3390/molecules24183248] [PMID: 31489932]
[13]
Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006; 58(1): 87-114.
[http://dx.doi.org/10.1124/pr.58.1.6] [PMID: 16507884]
[14]
Stamp LK, O’Donnell JL, Zhang M, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum 2011; 63(2): 412-21.
[http://dx.doi.org/10.1002/art.30119] [PMID: 21279998]
[15]
Becker MA, Schumacher HR, Espinoza LR, et al. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther 2010; 12(2): R63.
[http://dx.doi.org/10.1186/ar2978] [PMID: 20370912]
[16]
Vimala S, Mohd IA, Abdull RA, Rohana S. Nature’s choice to wellness: antioxidant vegetables/ulam. Kuala Lumpur: Forest Research Institute Malaysia 2003. Available from: https://agris.fao.org/agris-search/search.do?recordID=MY2011050052
[17]
Vimala S, Adenan MI. Malaysian tropical forest medicinal plants: a source of natural antioxidants. J Trop For Prod 1999; 5: 32-8.
[18]
Noor Hashim NH, Abas F, Shaari K, Lajis NH. Antioxidant and xanthine oxidase inhibitory activities of Persicaria hydropiper. Int J Food Prop 2013; 16(5): 1028-36.
[http://dx.doi.org/10.1080/10942912.2011.575497]
[19]
Rehman S, Choe K, Yoo H. Review on a traditional herbal medicine, Eurycoma longifolia Jack (Tongkat Ali): its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules 2016; 21(3): 331.
[http://dx.doi.org/10.3390/molecules21030331] [PMID: 26978330]
[20]
Bhat R, Karim AA. Tongkat Ali (Eurycoma longifolia Jack): A review on its ethnobotany and pharmacological importance. Fitoterapia 2010; 81(7): 669-79.
[http://dx.doi.org/10.1016/j.fitote.2010.04.006] [PMID: 20434529]
[21]
Varghese CP, C A, Jin SC, Lim YJ, Keisaban T. Antioxidant and anti-inflammatory activity of Eurycoma longifolia Jack, a traditional medicinal plant in Malaysia. Int J Pharm Sci Nanotechnol 2013; 5(4): 1875-8.
[http://dx.doi.org/10.37285/ijpsn.2012.5.4.7]
[22]
Liang P, Zhu L, Chen Y, et al. Experimental study on the anti-hyperuricemia effect of different extracts of Tongkat Ali. China Pharmacist 2018; 21: 224-7.
[23]
Bao R, Liu M, Wang D, et al. Effect of Eurycoma longifolia stem extract on uric acid excretion in hyperuricemia mice. Front Pharmacol 2019; 10(1464): 1464.
[http://dx.doi.org/10.3389/fphar.2019.01464] [PMID: 31920654]
[24]
Mohammad MK, Almasri IM, Tawaha K, et al. Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus. Pharm Biol 2010; 48(12): 1376-83.
[http://dx.doi.org/10.3109/13880209.2010.483521] [PMID: 20738177]
[25]
Rahmi EP, Kumolosasi E, Jalil J, et al. Anti-hyperuricemic and anti-inflammatory effects of Marantodes pumilum as potential treatment for gout. Front Pharmacol 2020; 11: 289.
[http://dx.doi.org/10.3389/fphar.2020.00289] [PMID: 32256360]
[26]
Abu-Gharbieh E, Shehab NG, Almasri IM, Bustanji Y. Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid: In vitro and in vivo investigation and docking simulations. PLoS One 2018; 13(8): e0202572.
[http://dx.doi.org/10.1371/journal.pone.0202572] [PMID: 30114281]
[27]
Choudhary YK, Bommu P, Ming YK, Zulkawi NB. Acute, subacute, and subchronic 90-days toxicity of Eurycoma longifolia aqueous extract (Physta) in Wistar rats. Int J Pharm Pharm Sci 2012; 4: 232-438.
[28]
Ming YK, Zulkawi NB, Vandana KC, Choudhary YK. Acute and sub-acute oral toxicity of Polygonum minus aqueous extract (Biotropics® pm101) in Wistar rats. Int J Pharm Pharm Sci 2013; 5: 120-4.
[29]
Haidari F, Rashidi MR, Keshavarz SA, Mahboob SA, Eshraghian MR, Shahi MM. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak J Biol Sci 2008; 11(14): 1779-84.
[http://dx.doi.org/10.3923/pjbs.2008.1779.1784] [PMID: 18817216]
[30]
Oh DR, Kim JR, Choi CY, et al. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1. BMC Complement Altern Med 2019; 19(1): 10.
[http://dx.doi.org/10.1186/s12906-018-2415-2] [PMID: 30621705]
[31]
Hatano T, Yasuhara T, Yoshihara R, Agata I, Noro T, Okuda T. Effects of interaction of tannins with co-existing substances. VII. Inhibitory effects of tannins and related polyphenols on xanthine oxidase. Chem Pharm Bull 1990; 38(5): 1224-9.
[http://dx.doi.org/10.1248/cpb.38.1224] [PMID: 2393948]
[32]
Amat N, Umar A, Hoxur P, et al. Traditional uighur medicine karapxa decoction, inhibits liver xanthine oxidase and reduces serum uric acid concentrations in hyperuricemic mice and scavenges free radicals in vitro. BMC Complement Altern Med 2015; 15(1): 131.
[http://dx.doi.org/10.1186/s12906-015-0644-1] [PMID: 25906842]
[33]
Nagao A, Seki M, Kobayashi H. Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol Biochem 1999; 63(10): 1787-90.
[http://dx.doi.org/10.1271/bbb.63.1787] [PMID: 10671036]
[34]
Mo SF, Zhou F, Lv YZ, Hu QH, Zhang DM, Kong LD. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol Pharm Bull 2007; 30(8): 1551-6.
[http://dx.doi.org/10.1248/bpb.30.1551] [PMID: 17666819]
[35]
Vimala S, Rohana S, Rashih AA, Juliza M. Antioxidant evaluation in Malaysian medicinal plant: Persicaria minor (Huds.) leaf. Sci J Med Clin Trials 2011; 1: 9-16.
[36]
Christapher P, Parasuraman S, Christina JA, Vikneswaran M, Asmawi MZ. Review on Polygonum minus. Huds, a commonly used food additive in Southeast Asia. Pharmacognosy Res 2015; 7(1): 1-6.
[http://dx.doi.org/10.4103/0974-8490.147125] [PMID: 25598627]
[37]
Day AJ, Bao Y, Morgan MRA, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 2000; 29(12): 1234-43.
[http://dx.doi.org/10.1016/S0891-5849(00)00416-0] [PMID: 11118813]
[38]
Iio M, Moriyama A, Matsumoto Y, Takaki N, Fukumoto M. Inhibition of xanthine oxidase by flavonoids. Agric Biol Chem 1985; 49: 2173-6.
[39]
Khanam Z, Wen CS, Bhat IUH. Phytochemical screening and antimicrobial activity of root and stem extracts of wild Eurycoma longifolia Jack (Tongkat Ali). J King Saud Univ Sci 2015; 27(1): 23-30.
[http://dx.doi.org/10.1016/j.jksus.2014.04.006]
[40]
Zhu H, Cao R. The relationship between serum levels of uric acid and prognosis of infection in critically ill patients. World J Emerg Med 2012; 3(3): 186-90.
[http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2012.03.005] [PMID: 25215061]
[41]
Chinnappan SM, George A, Thaggikuppe P, et al. Nephroprotective effect of herbal extract Eurycoma longifolia on paracetamol induced nephrotoxicity in rats. Evid Based Complement Alternat Med 2019; 2019(4916519): 1-6.
[http://dx.doi.org/10.1155/2019/4916519]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy